Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

Completed · Not applicable

Conditions studied: Kidney Failure, Chronic, End-Stage Renal Disease

In brief

The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.

Key facts

Study ID

NCT00667511

Run by

NxStage Medical

People needed

58

Starts

2008-04-01

Expected to finish

2014-05-01

Last updated by the study team

2015-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a stable prescription in the short daily home environment using the NxStage System One prior to enrollment.

You may not qualify if…

• Patients are not eligible if:
• they are currently enrolled in another drug or device study which could impact the successful completion of this study
• they are currently on NHD, or less than 3 months since discontinuing NHD
• if they were previously enrolled in this study.

Where it is running

• Satellite Healthcare/Wellbound — San Jose, California, United States
• Circle Medical Management — Chicago, Illinois, United States
• Indiana University Dialysis Center — Indianapolis, Indiana, United States
• Kansas Nephrology Research Institute, LLC — Wichita, Kansas, United States
• Barnes Jewish Dialysis Center — St Louis, Missouri, United States
• Dialysis Center of Lincoln — Lincoln, Nebraska, United States
• Rubin Dialysis — Saratoga Springs, New York, United States
• DaVita Grapevine at Home — Grapevine, Texas, United States
• DaVita Bluemound Home Dialysis — Wauwatosa, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.